SCHEMBL22553765

SCHEMBL22553765

O=C(NCc1ncco1)c1cc2c(-c3cncc(-c4ccc(N5CCCC5=O)cc4)c3)ccnc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 1/20 0.41
NUDT1 P36639 2/20 0.40
ROCK2 O75116 1/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
NPC1 O15118 1/20 0.38
METTL3 Q86U44 1/20 0.37
METTL14 Q9HCE5 1/20 0.37
LMNA P02545 3/20 0.37
GALR3 O60755 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22554047 0.88 DGAT2 (0.44) DGAT2NUDT1TBK1NPC1METTL3
SCHEMBL30730846 0.88 DGAT2 (0.44) DGAT2NUDT1TBK1NPC1METTL3
SCHEMBL22553982 0.88 DGAT2 (0.41) DGAT2NUDT1HPGDCYP1A2TBK1
SCHEMBL22554129 0.88 METTL3 (0.46) DGAT2NUDT1TBK1NPC1METTL3
SCHEMBL30730856 0.87 NUDT1 (0.47) DGAT2NUDT1TBK1METTL3METTL14
SCHEMBL22554104 0.87 NUDT1 (0.47) DGAT2NUDT1TBK1METTL3METTL14
SCHEMBL22554049 0.86 METTL3 (0.42) DGAT2NUDT1ROCK2HPGDCYP1A2
SCHEMBL22554015 0.86 DGAT2 (0.43) DGAT2NUDT1ROCK2HPGDCYP1A2
SCHEMBL30730866 0.86 DGAT2 (0.43) DGAT2NUDT1ROCK2HPGDCYP1A2
SCHEMBL22554303 0.85 CCNK (0.50) DGAT2NUDT1HPGDTBK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US claimed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP claimed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C DGAT2 4196/4885NUDT1 2148/4885ROCK2 1231/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C DGAT2 4196/4885NUDT1 2148/4885ROCK2 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.